"The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended restricting the use of codeine for cough and cold in children because there is a risk for serious adverse effects, including respiratory"...
TESSALON (benzonatate) acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. TESSALON (benzonatate) has no inhibitory effect on the respiratory center in recommended dosage.
Prescribing Document Revised: January 2011This monograph has been modified to include the generic and brand name in many instances.
Additional Tessalon Information
Tessalon - User Reviews
Tessalon User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration